MYRIP
Reactivité: Humain, Chien, Singe
WB
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
Peptide ELISA: Limit dilution 1/64000. Western blot: Use at 0.1-0.3 μg/mL. Approx 90 kDa band observed in Human Brain(Amygdala) lysates (Calculated MW of 95.0 kDa according to NP_056275.2). Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Restrictions
For Research Use only
Concentration
0.5 mg/mL
Buffer
Tris-saline, pH 7.3 containing 0.02 % Sodium Azide as preservative and 0.5 % BSA as stabilizer.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Conseil sur la manipulation
Avoid repeated freezing and thawing.
Stock
4 °C/-20 °C
Stockage commentaire
Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C.
Antigène
MYRIP
(Myosin VIIA and Rab Interacting Protein (MYRIP))
A molecular complex composed of Rab27A, MYRIP and myosin VIIa bridges retinal melanosomes to the actin cytoskeleton and thereby mediates the local trafficking of these organelles. The defect of this molecular complex is likely to account for the perinuclear mislocalization of the melanosomes observed in the retinal pigment epithelium cells of myosin VIIa-defective mice.Synonyms: Exophilin-8, Myosin-VIIa- and Rab-interacting protein, Rab effector MyRIP, SLAC2C, SlaC2-c, Slp homolog lacking C2 domains c